A rare-disease federal incentive program critical to biotech R&D is in jeopardy, writes Leslie Williams, president and CEO of ...

A rather odd week in venture, as the biggest rounds were raised by greentech, business travel and charity startups. Of course ...

Dr Vivienne Cox believes that carbohydrates and sweet treats were fuelling her body and keeping amyotrophic lateral sclerosis ...

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

Fortress Biotech Inc (NASDAQ:FBIO) shares are trading lower by 18.5% to $1.49 Friday afternoon after the company announced ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Vanguard Group, a US-based financial services company, has purchased shares in seven Indian companies, including Concord ...

Warren Buffett's strategy of investing in companies with strong moats can be applied to REITs for building a solid investment ...

Novo Nordisk announced Phase 2a trial results for monlunabant. The trial demonstrated a weight reduction of 7.1 kg with a 10 ...

An office and lab property in Thousand Oaks has sold in an all-cash transaction. Los Angeles-based Alta West Partners and an ...

After CEO Kevin Lobo promised earlier this summer a “bullish” M&A pipeline, Stryker is following through with its seventh ...